Related Experiment Videos
Prostaglandin E2 protects lower airways against bronchoconstriction.
John M Hartney1, Kenneth G Coggins, Stephen L Tilley
1Curriculum in Genetics and Molecular Biology, University of North Carolina, Chapel Hill, NC 27599, USA.
Summary
Elevating Prostaglandin E2 (PGE2) levels in the lungs genetically reduces airway resistance to bronchoconstriction. However, reducing PGE2 production or response does not affect airway reactivity to cholinergic stimuli.
Area of Science:
- Pulmonary pharmacology
- Respiratory system physiology
- Molecular biology
Background:
- Prostaglandin E2 (PGE2) is known to protect airways from bronchoconstriction, similar to beta-adrenergic agonists.
- Its role in regulating airway resistance under conditions of altered metabolism or signaling requires further investigation.
Purpose of the Study:
- To investigate the impact of sustained alterations in Prostaglandin E2 (PGE2) pathways on airway resistance.
- To determine how genetic modifications affecting PGE2 metabolism and signal transduction influence airway hyperresponsiveness.
Main Methods:
- Utilized genetic methods in murine models to manipulate PGE2 levels.
- Generated mice lacking the PGE2 catabolic enzyme (15-hydroxyprostaglandin, Hpgd-/-).
- Created transgenic mice with enhanced PGE2 synthase (Ptges) expression (hSP-C-Ptges).
- Examined mice deficient in PGE2 synthase (Ptges-/-) and the EP2 receptor (Ptger2).
Main Results:
- Diminished PGE2 production or signaling did not alter responses to cholinergic stimuli.
- Elevated PGE2 levels in Hpgd-/- and hSP-C-Ptges mice significantly attenuated airway responsiveness to methacholine.
- Lung resistance measurements indicated reduced airway reactivity in mice with increased PGE2.
Conclusions:
- Genetic elevation of lung Prostaglandin E2 (PGE2) levels attenuates airway responsiveness.
- Compromising the PGE2 synthesis/signaling pathway (Ptges/PGE2/Ptger2) does not impact baseline airway responsiveness.